India's Pharmaceutical Exports

Country Profile

Nepal

Nepal is a major destination for Indian pharmaceutical exports — $289M in FY 2025–26, with 1.8× growth over the past decade. Medicines accounts for 75% of shipments, with vaccines contributing $9.11M. The compound annual growth rate since FY2015 stands at 5.5%.

🇳🇵 #18 Destination · $289M · 1.8× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$289M
Exports FY2025–26 DGCIS
1.8×
Growth FY2015→2026
0.9%
Share of India Total
#18
Rank Among 178 Markets
5.5%
CAGR FY2015→2026
Nepal is a major destination for Indian pharmaceutical exports — $289M in FY 2025–26, with 1.8× growth over the past decade. Medicines accounts for 75% of shipments, with vaccines contributing $9.11M. The compound annual growth rate since FY2015 stands at 5.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $216M (74.8%) Medicine Ingredients $28.5M (9.9%) Surgical & Hospital Supplies $18.7M (6.5%) Traditional & Herbal $16.4M (5.7%) Vaccines $9.11M (3.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Nepal in the RBI overseas direct investment dataset (2011–2026).